Table 3. Clinicopathological features seen in patients with breast cancer.
| Variable | No. of patients (%) |
|---|---|
| Age of onset (yr) | |
| 50–59 | 171 (49.0) |
| 60–69 | 144 (41.3) |
| 70–79 | 33 (9.5) |
| 80–89 | 1 (0.3) |
| Histologic grade | |
| 1 | 59 (20.2) |
| 2 | 142 (48.6) |
| 3 | 91 (31.2) |
| ER | |
| Positive | 155 (54.2) |
| Negative | 131 (45.8) |
| PR | |
| Positive | 126 (44.4) |
| Negative | 158 (55.6) |
| HER2 | |
| Positive | 98 (34.6) |
| Negative | 170 (60.1) |
| Equivocal | 15 (5.3) |
| Triple negative | 64 (22.1) |
| Lymph node involvement | |
| Positive | 174 (57.8) |
| Negative | 127 (42.2) |
ER=estrogen receptor; PR=progesterone receptor; HER2=human epidermal growth factor receptor 2.